ALSO IN THIS MONTH'S ISSUE

BEYOND THE PRINTED PAGE

  • A Behind The Scenes Look Into Enanta’s CEO, Jay Luly

    From Big Pharma, to small biotech, to a VC, and then back to small biotech, Jay Luly, Ph.D., CEO of Enanta Pharmaceuticals, has seen his fair share of change in this ever-changing industry. 

  • We Need To Expand How We Value Companies

    During an interview for an upcoming feature in Life Science Leader, Sanjeev Redkar, Ph.D., cofounder and president of Apollomics (a biopharmaceutical company discovering and developing oncology treatments), discussed the topic of an exit strategy.

  • Have You Heard Of The Chinese Biopharmaceutical Association (CBA)?

    While working at his first job at Human Genome Sciences in 1995, Guo-Liang Yu, Ph.D., decided to create The Chinese Biopharmaceutical Association (CBA), one of the largest Chinese American professional associations in the U.S.

MARCH 2021 DIGITAL EDITION

2021 CMO AWARDS EDITION

   

@RFWRIGHTLSL

@LIFESCILEADER1